Chlamydia pneumoniae and atherosclerosis: From Koch's postulates to clinical trials

Progress in Cardiovascular Diseases

Volumn 47, Issue 4, 2005, Pages 230-239

  Liu, Catherine ^b   Waters, David D ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; GATIFLOXACIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROXITHROMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ATHEROGENESIS; ATHEROSCLEROSIS; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISEASE MODEL; EXPERIMENTAL INFECTION; HEART PROTECTION; HISTOPATHOLOGY; HOST; HUMAN; INFECTION; INFLAMMATION; INOCULATION; MICROBIOLOGY; NONHUMAN; PATHOGENESIS; REVIEW; SECONDARY PREVENTION; SEROEPIDEMIOLOGY; TREATMENT OUTCOME; UNCERTAINTY;

EID: 20744459459     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2005.01.001     Document Type: Article

References (46)

1. C. Frothingham The relation between acute infectious diseases and arterial lesions Arch Intern Med 8 1911 153 162
2. C.R. Minick, C.G. Fabricant, and J. Fabricant Atheroarteriosclerosis induced by infection with a herpesvirus Am J Pathol 96 1979 673 706
3. M.T. Grattan, C.E. Moreno-Cabral, and V.A. Starnes Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis JAMA 261 1989 3561 3566
4. M.T. Grattan Accelerated graft atherosclerosis following cardiac transplantation: Clinical perspectives Clin Cardiol 14 1991 16 20
5. K.M. McDonald, T.S. Rector, and E.A. Braunlin Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection Am J Cardiol 64 1989 359 362
6. Y.F. Zhou, M.B. Leon, and M.A. Waclawiw Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy N Engl J Med 335 1996 624 630
7. P.D. Sorlie, F.J. Nieto, and E. Adam A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study Arch Intern Med 160 2000 2027 2032
8. P.M. Ridker, C.H. Hennekens, and M.J. Stampfer Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke Circulation 98 1998 2796 2799
9. D.S. Siscovick, S.M. Schwartz, and L. Corey Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus, and incident myocardial infarction and coronary heart disease death in older adults: The cardiovascular health study Circulation 102 2000 2335 2340
10. J. Danesh, R. Collins, and R. Peto Chronic infections and coronary heart disease: Is there a link? Lancet 350 1997 430 436
11. V. Pasceri, G. Cammarota, and G. Patti Association of virulent Helicobacter pylori strains with ischemic heart disease Circulation 97 1998 1675 1679
12. C. Espinola-Klein, H.J. Rupprecht, and S. Blankenberg Impact of infectious burden on extent and long-term prognosis of atherosclerosis Circulation 105 2002 15 21
13. H.J. Rupprecht, S. Blankenberg, and C. Bickel Impact of viral and bacterial infectious burden on long-term prognosis of patients with coronary artery disease Circulation 104 2001 25 31
14. S. Kiechl, G. Egger, and M. Mayr Chronic infections and the risk of carotid atherosclerosis: Prospective results from a large population study Circulation 103 2001 1064 1070
15. C.C. Kuo, L.A. Jackson, and L.A. Campbell Chlamydia pneumoniae Clin Microbiol Rev 8 1995 451 461
16. L.A. Campbell, C.C. Kuo, and J.T. Grayston Chlamydia pneumoniae and cardiovascular disease Emerg Infect Dis 4 1998 571 579
17. P. Saikku, M. Leinonen, and K. Mattila Serologic evidence for an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction Lancet 2 1988 983 986
18. P. Saikku, M. Leinonen, and L. Tenkanen Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study Ann Intern Med 116 1992 273 278
19. T. Huittinen, M. Leinonen, and L. Tenkanen Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk Circulation 107 2003 2566 2570
20. J. Boman, and M.R. Hammerschlag Chlamydia pneumoniae and atherosclerosis: Critical assessment of diagnostic methods and relevance to treatment studies Clin Microbiol Rev 15 2002 1 20
21. A. Kutlin, P.M. Roblin, and M.R. Hammerschlag Antibody response to Chlamydia pneumoniae infection in children with respiratory illness J Infect Dis 177 1998 720 724
22. C.L. Hyman, P.M. Roblin, and C.A. Gaydos Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: Assessment by polymerase chain reaction-enzyme immunoassay and culture Clin Infect Dis 20 1995 1174 1178
23. J. Danesh, P. Whincup, and M. Walker Chlamydia pneumoniae IgG titres and coronary heart disease: Prospective study and meta-analysis BMJ 321 2000 208 213
24. D.G. Bloemenkamp, W.P. Mali, and F.L. Visseren Meta-analysis of sero-epidemiologic studies of the relation between Chlamydia pneumoniae and atherosclerosis: Does design influence results? Am Heart J 145 2003 409 417
25. A. Shor, C.C. Kuo, and D.L. Patton Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques S Afr Med J 82 1992 158 161
26. R.G. Gibbs, N. Carey, and A.H. Davies Chlamydia pneumoniae and vascular disease Br J Surg 85 1998 1191 1197
27. J.A. Ramirez Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis Ann Intern Med 125 1996 979 982
28. M. Maas, C. Bartels, and P.M. Engel Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease J Am Coll Cardiol 31 1998 827 832
29. S.M. Weiss, P.M. Roblin, and C.A. Gaydos Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy J Infect Dis 173 1996 957 962
30. I.W. Fong, B. Chiu, and E. Viira Rabbit model for Chlamydia pneumoniae infection J Clin Microbiol 35 1997 48 52
31. K. Laitinen, A. Laurila, and L. Pyhala Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits Infect Immun 65 1997 4832 4835
32. T.C. Moazed, L.A. Campbell, and M.E. Rosenfeld Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice J Infect Dis 180 1999 238 241
33. J.B. Muhlstein, J.L. Anderson, and E.H. Hammond Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model Circulation 97 1998 633 636
34. C. Dosquet, D. Weill, and J.L. Wautier Cytokines and thrombosis J Cardiovasc Pharmacol 25 1995 13 19
35. K. Sakayama, H. Masuno, and H. Okumura Recombinant human tumor necrosis factor-alpha suppresses synthesis, activity, and secretion of lipoprotein lipase in cultures of human osteosarcoma cell line Biochem J 316 1996 813 817
36. P. Libby, D. Egan, and S. Skarlatos Role of infectious agents in atherosclerosis and restenosis: An assessment of the evidence and need for future research Circulation 96 1997 4095 4103
37. A. Kol, G.K. Sukhova, and A.H. Lichtman Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression Circulation 98 1998 300 307
38. S. Gupta, E.W. Leatham, and D. Carrington Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction Circulation 96 1997 404 407
39. E. Gurfinkel, G. Bozovich, and E. Beck Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study Eur Heart J 20 1999 121 127
40. J.B. Muhlstein, J.L. Anderson, and J.F. Carlquist Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: Preliminary clinical results of the ACADEMIC study Circulation 102 2000 1755 1760
41. J. Sinisalo, K. Mattila, and V. Valtonen Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-Q-wave coronary syndrome Circulation 105 2002 1555 1560
42. C. O'Connor, M.W. Dunne, and M.A. Pfeffer Azithromycin for the secondary prevention of coronary heart disease events. The WIZARD study: A randomized controlled trial JAMA 290 2003 1459 1466
43. P. Brassard, C. Bourgault, and J. Brophy Antibiotics in primary prevention of myocardial infarction in elderly patients with hypertension Am Heart J 145 2003 E20
44. F. Neumann, A. Kastrati, and T. Miethke Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointimal proliferation after coronary stent placement (ISAR-3): A randomized, double-blind, placebo-controlled trial Lancet 357 2001 2085 2089
45. J. Ngeh, V. Anand, and S. Gupta Chlamydia pneumoniae and atherosclerosis-what we know and what we don't Clin Microbiol Infect 8 2002 2 13
46. E.V. Gelfand, and C.P. Cannon Antibiotics for secondary prevention of coronary artery disease: An ACES hypothesis but we need to PROVE IT Am Heart J 147 2004 202 209